| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.006 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.088 | 0.006 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.12 | 0.006 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.13 | 0.006 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.006 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.097 | 0.007 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.008 |